These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 503884)

  • 1. [Study of phospholipids in primary hyperlipoproteinemias].
    Kuczyńska K
    Pol Arch Med Wewn; 1979 Jul; 62(1):29-40. PubMed ID: 503884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia.
    Schonfeld G; George PK; Miller J; Reilly P; Witztum J
    Metabolism; 1979 Oct; 28(10):1001-10. PubMed ID: 226830
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H; Merk W; Falkner C; Hiller E
    Thromb Res; 1986 Feb; 41(3):281-9. PubMed ID: 3705010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 7. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease].
    Mikhailova IA; Lipovetskiĭ BM; Magracheva EIa; Gurevich VS
    Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
    Reiner Z; Salzer B; Kes P
    Acta Med Iugosl; 1988; 42(5):353-62. PubMed ID: 3245481
    [No Abstract]   [Full Text] [Related]  

  • 10. Behaviour of platelet adhesiveness and of dilute clot blood lysis time in hyperlipoproteinemic subjects.
    Zdrenghea D; Stef C; Cucuianu M; Vlaicu R
    Med Interne; 1979; 17(3):273-7. PubMed ID: 504931
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl].
    Ol'binskaia LI; Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Ter Arkh; 1991; 63(8):61-4. PubMed ID: 1792621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta 2 glycoprotein I analysis in patients with hyperlipoproteinemia, arteriosclerotic occlusive disease and diabetes mellitus].
    Müller G; Biering A; Lux E; Richter V
    Z Gesamte Inn Med; 1983 May; 38(10):282-4. PubMed ID: 6613192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood and plasma hyperviscosity in primary hyperlipidemia].
    Ozanne P; Boudart D; Mainard F; Lefebvre J; Grolleau JY
    Rev Med Interne; 1984 Mar; 5(1):29-33. PubMed ID: 6718836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of free apolipoprotein A-1 concentration in serum, and its measurement in normal and hyperlipidemic subjects.
    Neary RH; Gowland E
    Clin Chem; 1987 Jul; 33(7):1163-9. PubMed ID: 3109778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
    Leijd B
    Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperlipoproteinemias.
    Whayne TF
    J Fam Pract; 1980 Nov; 11(5):789-99. PubMed ID: 7430980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlipoproteinemias as risk factors for ischemic cardiopathy: new diagnostic possibilities].
    Gaddi A; Scaramuzzino G; Benassi MS; Aluigi L; Ceredi C; Albertazzi I; Suffritti G; Descovich GC
    Boll Soc Ital Cardiol; 1978; 23(9):1537-44. PubMed ID: 553627
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.